Gitte aabo biography of william

The e-health space and big data present important opportunities for the pharma industry to help patients. Some of the data gathered through these new technologies can potentially be used to support early diagnosis through prediction models based on internet behaviour and search patterns. Digitalisation presents a new opportunity to help patients but also demands that the industry prepares for the next frontier in data protection.

We established LEO Innovation Lab precisely with e-health in mind; an innovation unit that develops digital solutions to help people with psoriasis. The platform also conducts surveys to map the personal experiences that people living with psoriasis have with specific diets, foods, beverages or nutrients and how these affect their psoriasis.

By addressing the foods most Googled in connection with psoriasis, we can address some of the dietary components that people with psoriasis want to know more about and, therefore, use health data to improve our offering to patients. The future of pharma lies in becoming even better at integrating patient insights into the business. This is the key to meeting patient needs.

In addition to delivering efficacious, safe and convenient treatments, a big part of this journey will be understanding the opportunities in the digital space. I expect to see new players such as Google and Apple entering the health sector. Our future as an industry also lies in partnerships and I expect to see more of these. Patient-centricity is not just about focusing on patients but on the many stakeholders around the patient.

Be humble and do your best. You should always be prepared to revisit a decision — even when it was your own idea. One piece of good advice that stands out for me came from our former chairman, Poul Rasmussen. To be perfect is to change often. Launch the PharmaTimes digital editon app. PharmaTimes Media Ltd. With a […]. The CEO of Lundbeck, who announced that she will retire last week, did not initially intend to join the life science industry, but it captivated her more than 30 years ago, and the ability to transform lives still drives her to this day.

For more than years, Lundbeck has been at the forefront of […]. For the past 14 years Jutta Heix has been an important cog in the wheel in accelerating the development of new cancer treatments and diagnostics — connecting and helping innovators and putting Norwegian oncology on the global map. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.

Subscribe Sign in. Profiles in Business. Ellen R. The potential of health data Times are challenging for leaders in the pharmaceutical industry as companies face more issues and criticisms. Top stories. Pharma Business — January 29, Clinical Trials — January 29, In a new job — January 28, Follow NLS news. Related posts. Profiles in Business - April 23, Business article - April 17, Business - November 28, Business - November 1, Profiles in Business - July 3, Profiles in Business - February 13, Deputy Chair of the Board.

Special competencies Arthur is a global executive with extensive business development, marketing and leadership expertise from large healthcare companies in both the US and Europe, holding CEO positions at Bayer HealthCare and Assertio Therapeutics, and senior executive roles at Abbott Laboratories. Education Arthur Higgins holds a B. Nationality British and American.

Board Member. Elected to the Board of Directors in and is regarded as an independent board member. Special competencies Gitte brings extensive global leadership experience from the life science industry and a deep understanding of dermatology, marketing, and technology markets. Education Gitte P. Nationality Australian.

Gitte aabo biography of william

Peter Kristensen. Current positions Independent consultant. Rasmus Toft-Kehler. Special competencies Extensive leadership and strategic development experience from founding and building companies in the life science industry. Education Rasmus holds a Ph. Morten Sommer. Special competencies Extensive research and development experience working within fields of drug development, industrial biotechnology and microbiome research.